Skip to main content
Glama

Corporate Apology

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate read-only, idempotent, non-destructive. The description adds specific behavioral details: data sources (SEC EDGAR/XBRL, FAERS), fiscal year handling, sorting by primary metric, and citation URIs in the response. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense with information and front-loaded with trigger phrases. Every sentence adds value, though the length and heavy use of uppercase might be slightly overwhelming; a bit more structure could improve readability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema exists, but the description adequately describes return format (paired data + citation URIs), sorting behavior, and data source coverage. It also handles edge cases like off-calendar fiscal years, making the tool's behavior fully predictable.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers parameters, but description goes further by specifying what metrics are pulled for each type: company (10-K revenue, net income, cash, long-term debt) and drug (FAERS counts, approval counts, trial counts). Also clarifies array limits and examples.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states 'side-by-side comparison of 2–5 companies or drugs in ONE parallel call' and includes user-phrase examples. It clearly distinguishes from sequential lookups and sibling tools like entity_profile by focusing on multi-entity comparison.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit guidance: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' It also lists concrete trigger phrases, giving the agent clear conditions for when to invoke this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation4/5

Most tools have clearly distinct purposes with detailed descriptions. Some overlap exists in the Polymarket-related tools, but each has a specific focus (arbitrage detection, edge scanning, persistence tracking, fill risk, cross-venue spread). The two ask_pipeworx variants are similar but differentiated by hallucination resistance.

Naming Consistency5/5

All tool names use lowercase with underscores, following a consistent pattern of verb_noun or noun_verb. Examples include 'ai_visibility_check', 'bet_research', 'entity_profile', and 'validate_claim'. There are no mixed conventions or erratic naming.

Tool Count2/5

The server is named 'Corporate Apology' but contains 31 tools, only one of which (corporate_apology_generate) relates to apologies. The vast majority are unrelated data retrieval and analysis tools, making the count excessive and poorly scoped for the server's stated purpose.

Completeness1/5

For a server focused on corporate apologies, the only tool is corporate_apology_generate. There are no tools for analyzing apology impact, managing crisis response, or tracking apologies. The tool surface is severely incomplete relative to the server's name.